Literature DB >> 24674466

The biological consequences of replacing D-Ala in biphalin with amphiphilic α-alkylserines.

Oliwia Frączak1, Anika Lasota, Anna Leśniak, Andrzej W Lipkowski, Aleksandra Olma.   

Abstract

Biphalin, a synthetic opioid peptide with a broad affinity for all opioid receptors (δ, μ, and κ) and high antinociceptive activity, has been under extensive study as a potential analgesic drug. This study presents the synthesis and biological properties of four new analogues of biphalin containing amphiphilic α-alkylserines in position 2 and 2'. The incorporation of bulky α,α-disubstituted amino acids in the peptide chain using standard peptide chemistry is often unsuccessful. We synthesized depsipeptides, and then, the desired peptides were obtained by internal O,N-migration of the acyl residue from the hydroxyl to the amino group under mild basic conditions. The potency and selectivity of the new analogues were evaluated by a competitive receptor-binding assay in the rat brain using [(3)H]DAMGO (a μ ligand) and [(3)H]DELT (a δ ligand). Their binding affinity is strongly dependent on the chirality of α-alkylserine, as analogues containing (R)-α-alkylserines displayed higher μ receptor affinity and selectivity than those incorporating the (S)-isomers.
© 2014 John Wiley & Sons A/S.

Entities:  

Keywords:  O,N-migration; O-acyl isopeptides; amphiphilic amino acids; biphalin analogues; opioid activities; opioid peptides; α-alkylserines

Mesh:

Substances:

Year:  2014        PMID: 24674466     DOI: 10.1111/cbdd.12305

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  1 in total

1.  Cyclic Biphalin Analogues Incorporating a Xylene Bridge: Synthesis, Characterization, and Biological Profile.

Authors:  Azzurra Stefanucci; Alfonso Carotenuto; Giorgia Macedonio; Ettore Novellino; Stefano Pieretti; Francesca Marzoli; Edina Szűcs; Anna I Erdei; Ferenc Zádor; Sándor Benyhe; Adriano Mollica
Journal:  ACS Med Chem Lett       Date:  2017-07-12       Impact factor: 4.345

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.